Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - acetato de abiraterona - neoplasmas prostáticos - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unión Europea - español - EMA (European Medicines Agency)

krka, d.d., novo mesto - acetato de abiraterona - neoplasmas prostáticos - terapia endocrina - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - acetato de abiraterona - neoplasmas prostáticos - terapia endocrina - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unión Europea - español - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - próstata neoplasias, resistente a la castración - agentes antineoplásicos - treatment of adult patients with prostate cancer.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sandoz farmaceutica s.a. - abiraterona acetato - comprimido recubierto con pelÍcula - 500 mg - abiraterona acetato 500 mg - abiraterona

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios combix s.l.u. - abiraterona acetato - comprimido recubierto con pelÍcula - 500 mg - abiraterona acetato 500 mg - abiraterona

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cipla europe nv - abiraterona acetato - comprimido recubierto con pelÍcula - 500 mg - abiraterona acetato 500 mg - abiraterona

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

johnson & johnson del peru s.a. - acetato de abiraterona; - comprimido - por comprimido - acetato de abiraterona

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

perulab s.a. - droguerÍa - acetato de abiraterona; - comprimido - por comprimido - - abiraterona

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

biotoscana farma de peru s.a.c. - droguerÍa - acetato de abiraterona; - comprimido - por comprimido - - abiraterona